United States · FDA National Drug Code directory
Duloxetine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-282_ad4ac841-ec88-467d-9970-ccdbba56bd11
- Product NDC
- 59651-282
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- Duloxetine Hydrochloride
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20131211
- Source listing expiry
- 20261231
Source-listed ingredients
- DULOXETINE HYDROCHLORIDE — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (59651-282-30) · 59651-282-30
- 10 BLISTER PACK in 1 CARTON (59651-282-78) / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (59651-282-10) · 59651-282-78
- 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (59651-282-90) · 59651-282-90
- 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (59651-282-99) · 59651-282-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →